or
Bookmark and Share
Use of 3-indolepyruvic acid as a pharmaceutical agent for the inhibition of peripheral degenerative pathologies
   
Document Number
US Patent 5075329
Issued Date
December 24, 1991
Link
Map
Abstract
Indolepyruvic acid shows an inhibitory activity with respect to the degenerative action by oxygen free radical which are responsible for a number of pathologic conditions in various peripheral tissues. The compound can find application in miocardiopathies, inflammations, circulatory shock, arteriosclerosis, and cardiac ischemia.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
5
Comments:
no comments yet
Owner
Published
December 24, 1991
Application Number
07/394,861
Filed
August 17, 1989
US Classification
514/415  
Int'l Classification
A61K   31/405   (20060101)   A61K   31/403   (20060101)  
Assistant Examiner
Priority Data
Sep 29, 1988 [IT] 48398 A/88
USPTO Field of Search
514/415  
Related Patents
5447951 - Method for reducing the level of glucocorticoids in the blood and preventing cerebral disturbances - Owned by Polifarma S.p.A. (Roma,IT)

3-indolepyruvic acid is an active agent in preventing cerebral damage caused by stress and ageing and induced by an excessive presence in the blood of glucocorticoids, secreted by the adrenal gland.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us